- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02040727
Effect of Resistance Training on Musculoskeletal Endocrine Interactions (COMB)
Communications of Muscle and Bone
This project will evaluate the impact of resistance training on the synthesis and release of hormones and growth factors from the musculoskeletal system and the extent to which the communicative capacity influences glucose homeostasis In turn, the contribution of glucose regulation on the musculoskeletal system will also be evaluated. This small study will serve as a pilot/feasibility study to define a protocol for implementation of a resistance training intervention in the pediatric population. To establish feasibility, this study population is limited to overweight African American boys ages 7-11 years.
In light of well-established accolades of resistance training, historical recommendations for avoidance among the pediatric population have deterred implementation of resistance training interventions in young adolescents. However, contemporary data indicating a profound benefit of resistance training to the skeletal system in pre-adolescents has led to the Academy of Sports Medicine, as well as various other pediatric health interest groups, to support supervised programs incorporating resistance training in young children, emphasizing large muscle and core strengthening. To date, such trials have not been conducted in the pediatric population
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Early adolescence (pre-puberty) is associated with many physiological changes with the intersection of metabolic pathways and body composition at the core. Lifestyle behaviors provide substantial influence and the rise of sedentary behavior particularly among this population can exert profound disruption. Metabolic dysfunction associated with limited activity and thus limited strain on the muscles and bones is associated with poor musculoskeletal health. Metabolic disturbance within the system during critical periods of development such as pre-puberty confers long-term health consequences.
Communication across systems is reliant upon various hormones which interact on the regulation of glucose homeostasis, bone metabolism, and muscle development. While it is well-established that bone and muscle growth are dependent upon fuel utilization, factors secreted by bone and muscle have been recently shown to play an interactive role in glucose homeostasis. Data derived primarily from animal models have demonstrated maintenance of physiological levels promote optimal growth and development, whereas these hormones appear to have adverse effects when levels are altered. While the data in animals is compelling, translation in humans has not been conducted.
Speculatively, impaired glucose homeostasis, much attributable to decreased strain on the musculoskeletal system, promotes impairments in physiological roles of these hormones. As a result, disordered development may be of consequence, such that the bones grow bigger yet have impaired quality, and delivery of fuel to muscle is compromised. Obesity-induced perturbations in metabolism and tissue partitioning may be an added stress to the system, impairing muscle function, power, performance and overall quality. Strategies that optimize the protective effects of the musculoskeletal system may be encompassed by forced stress on the system via resistance training, known to influence synthesis and release of hormones involved in fuel delivery and utilization by muscle and bone. The strategy proposed will target optimization of musculoskeletal health, promoting synthesis and release of musculoskeletal-derived signals providing protection on metabolic health at a critical period of development.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- overweight
- early pubertal boys (Tanner stage <3)
- ages 7-12 years
- self-identified as Non-Hispanic Black.
Exclusion Criteria:
- type 1 or 2 diabetes
- musculoskeletal disorders
- disturbances in glucose or lipid metabolism
- use of thyroid medication, diuretics, beta-blockers, or any medication that potentially could affect body composition, the lipid profile, insulin sensitivity, or blood pressure
- allergy to EMLA cream
- history of eating disorders, cancer, kidney disease, endocrinopathy, liver disease, heart disease, or thyroid disease
- medically determined not to be able to engage in resistance training
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Non-Resistance Trained
No Participation in Resistance Training
|
No supervised strength training throughout the study
|
Experimental: Resistance Trained
Participation in Resistance Training
|
Supervised strength training 3 days per week for 24 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting plasma FGF-23 concentration
Time Frame: 0,8,12,16, 24 weeks
|
Fibroblast Growth Factor-23
|
0,8,12,16, 24 weeks
|
Fasting serum osteocalcin concentration
Time Frame: 0, 8, 12, 16, 24 weeks
|
0, 8, 12, 16, 24 weeks
|
|
Fasting serum insulin concentration
Time Frame: 0, 8, 12, 16, 24 weeks
|
0, 8, 12, 16, 24 weeks
|
|
Fasting serum glucose concentration
Time Frame: 0, 8, 12, 16, 24 weeks
|
0, 8, 12, 16, 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bone mineral content
Time Frame: 0, 12, 24 weeks
|
by DXA
|
0, 12, 24 weeks
|
Muscle strength
Time Frame: 0, 8, 12, 16, 24 weeks
|
0, 8, 12, 16, 24 weeks
|
|
Muscle density
Time Frame: 0, 12, 24 weeks
|
by pQCT
|
0, 12, 24 weeks
|
Bone stress-strain index
Time Frame: 0, 12, 24 weeks
|
by pQCT
|
0, 12, 24 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resting energy expenditure
Time Frame: 0, 12, 24 weeks
|
by indirect calorimetry
|
0, 12, 24 weeks
|
Total fat mass
Time Frame: 0, 12, 24 weeks
|
by DXA
|
0, 12, 24 weeks
|
Total lean mass
Time Frame: 0, 12, 24 weeks
|
by DXA
|
0, 12, 24 weeks
|
Collaborators and Investigators
Investigators
- Study Director: Orlando M Gutierrez, MD, MMSc, University of Alabama at Birmingham
- Principal Investigator: Lynae J Hanks, PhD, RD, University of Alabama at Birmingham
- Study Director: Krista Casazza, PhD, RD, University of Alabama at Birmingham
- Study Director: Marcas Bamman, PhD, University of Alabama at Birmingham
- Study Chair: Ambika Ashraf, MD, University of Alabama at Birmingham
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- COMB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Musculoskeletal and Metabolic Crosstalk
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recruiting
-
National Taiwan University HospitalRecruiting
-
Peking University Third HospitalRecruiting
-
Shinshu UniversityRecruiting
-
Shanghai University of Traditional Chinese MedicineGuangdong Provincial Hospital of Traditional Chinese Medicine; Gansu Provincial... and other collaboratorsRecruiting
-
National Taiwan University HospitalCompleted
-
Organon and CoCompleted
-
University of NebraskaCreighton University Medical CenterCompleted
-
Duquesne UniversityOsteoStrongActive, not recruiting
-
University Health Network, TorontoEli Lilly and CompanyActive, not recruiting
Clinical Trials on No Resistance Training
-
United States Department of DefenseCentral Virginia VA Health Care SystemRecruitingSpinal Cord InjuriesUnited States
-
Rigshospitalet, DenmarkCompleted
-
University of KasselCompleted
-
University of KasselUniversity of PotsdamCompleted
-
University of Applied Sciences of Western SwitzerlandCompleted
-
University of BarcelonaCompleted
-
University of AarhusAarhus University Hospital; University of Southern Denmark; Vejle Hospital; Naestved... and other collaboratorsActive, not recruiting
-
Vienna Hospital AssociationRecruiting
-
Universidade Federal do Triangulo MineiroUnknown
-
Universidade Federal de Sao CarlosConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedChronic Obstructive Pulmonary DiseaseBrazil